AUPP659198A0 - Mastitis treatment - Google Patents

Mastitis treatment

Info

Publication number
AUPP659198A0
AUPP659198A0 AUPP6591A AUPP659198A AUPP659198A0 AU PP659198 A0 AUPP659198 A0 AU PP659198A0 AU PP6591 A AUPP6591 A AU PP6591A AU PP659198 A AUPP659198 A AU PP659198A AU PP659198 A0 AUPP659198 A0 AU PP659198A0
Authority
AU
Australia
Prior art keywords
mastitis treatment
mastitis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP6591A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kazia Research Pty Ltd
Original Assignee
Novogen Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novogen Research Pty Ltd filed Critical Novogen Research Pty Ltd
Priority to AUPP6591A priority Critical patent/AUPP659198A0/en
Publication of AUPP659198A0 publication Critical patent/AUPP659198A0/en
Priority to AU11407/00A priority patent/AU1140700A/en
Priority to PCT/AU1999/000910 priority patent/WO2000023085A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AUPP6591A 1998-10-19 1998-10-19 Mastitis treatment Abandoned AUPP659198A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPP6591A AUPP659198A0 (en) 1998-10-19 1998-10-19 Mastitis treatment
AU11407/00A AU1140700A (en) 1998-10-19 1999-10-19 Mastitis treatment with particulate glucan
PCT/AU1999/000910 WO2000023085A1 (en) 1998-10-19 1999-10-19 Mastitis treatment with particulate glucan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP6591A AUPP659198A0 (en) 1998-10-19 1998-10-19 Mastitis treatment

Publications (1)

Publication Number Publication Date
AUPP659198A0 true AUPP659198A0 (en) 1998-11-12

Family

ID=3810812

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP6591A Abandoned AUPP659198A0 (en) 1998-10-19 1998-10-19 Mastitis treatment

Country Status (2)

Country Link
AU (1) AUPP659198A0 (en)
WO (1) WO2000023085A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
JPH05503952A (en) * 1989-09-08 1993-06-24 アルファ　ベータ　テクノロジー，インコーポレイティッド Method for producing soluble glucans
SE508760C2 (en) * 1997-04-29 1998-11-02 Medicarb Ab Use of a composition comprising chitosan in combination with a polysaccharide, as an active component in a solvent, for the preparation of a dairy dipping agent for milk producing animals

Also Published As

Publication number Publication date
WO2000023085A1 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
AUPP427398A0 (en) Improved disinfection
AU3485999A (en) Neo-tryptophan
AU7656800A (en) Milking arrangement
AU1772399A (en) Well treatment
AU3627899A (en) Coagulator
AU3437799A (en) City-car
AU3522399A (en) Carvedilol-galenics
AU5547000A (en) Novel treatment
AU5407599A (en) Sphingolipid-desaturase
AU3253699A (en) Myxochelines
AU4556800A (en) Novel treatment
AU1968200A (en) Pesticide treatment
AU2609599A (en) Sensor-coupling
AU2227999A (en) Human ependymin
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU1055399A (en) Rollerboard
AU5524399A (en) Inorgasmia treatment
AU6088099A (en) Water treatment
AU2202100A (en) Human brainiac-5
AUPP659198A0 (en) Mastitis treatment
AU3347599A (en) Aeromobile
AU5223199A (en) Bathtub-bathseat
AU3032299A (en) Fungicidal benzoheterocyclyloxime
AU2840799A (en) 1-phosphanorbornadienes

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 1140700

Country of ref document: AU